Indoco Remedies Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indoco Remedies Ltd. on BSE

Load latest

Indoco Remedies Ltd.

21 Jan 2025

324.30

1.66%

Board Meeting

INDOCO REMEDIES LTD. - 532612 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Pursuant to the Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 21st January, 2025 has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2024 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results.

pdf

Indoco Remedies Ltd.

21 Jan 2025

324.30

1.66%

Company Update

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Nomination and Remuneration Committee in its meeting held today i.e. 21st January, 2025 has approved the allotment of 65,700 equity shares of face value of Rs. 2 each to the Indoco Employees Welfare Trust under Indoco Remedies Limited Employee Stock Option Plan-2022.

pdf

Indoco Remedies Ltd.

15 Jan 2025

324.30

1.66%

Company Update

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

We wish to inform you that an Earnings Conference Call on unaudited financial results for the quarter and nine months ended 31-12-2024 is scheduled to be held on Tuesday,21st January 2025 at 03:30 P.M. IST.

pdf

Indoco Remedies Ltd.

15 Jan 2025

324.30

1.66%

Company Update

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

pdf

Indoco Remedies Ltd.

13 Jan 2025, 01:07PM

324.30

1.66%

Board Meeting

INDOCO REMEDIES LTD. - 532612 - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results …

BSE India

INDOCO REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2025 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31-12-2024

pdf

Indoco Remedies Ltd.

07 Jan 2025

324.30

1.66%

Company Update

INDOCO REMEDIES LTD. - 532612 - Change Of Name Of Registrar & Share Transfer Agent (RTA) …

BSE India

The Company has been informed by the Registrar & Share Transfer Agent (RTA) that they have changed their name from Link Intime India Pvt Ltd to MUFG Intime India Pvt Ltd wef 31-12-2024. The Certificate of incorporation pursuant to change of name is enclosed herewith.

pdf

Indoco Remedies Ltd.

07 Jan 2025

324.30

1.66%

Company Update

INDOCO REMEDIES LTD. - 532612 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Attached Certificate issued by MUFG Intime India Pvt Ltd (Formerly known as Link Intime India Pvt Ltd) Registrar & Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (DP)Regulations,2018 for the quarter ended 31-12-2024.

pdf

Indoco Remedies Ltd.

30 Dec 2024

324.30

1.66%

SAST

INDOCO REMEDIES LTD. - 532612 - Closure of Trading Window

BSE India

Intimation regarding Closure of Trading Window

pdf

Indoco Remedies Ltd.

17 Dec 2024

324.30

1.66%

Company Update

INDOCO REMEDIES LTD. - 532612 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015- …

BSE India

This is further to our notification dated October 11, 2024, for receipt of Official Action Indicated (OAI) status from the USFDA for Plant II & Plant III facility located at Goa (Facility). Subsequently the Facility has received a warning letter from USFDA on December 17, 2024. This Facility was inspected from July 16, 2024 to July 26, 2024.

pdf

Indoco Remedies Ltd.

10 Dec 2024

324.30

1.66%

Company Update

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 read with Schedule III OF THE SEBI (LODR) Regulation 2015, we wish to inform you that the management of the Company will be meeting investors and analysts (participants) hosted by Valorem Advisors on 17-12-2024 at 4.00 pm through virtual meet.

pdf

Is Indoco Remedies Ltd. worth buying?

60 Votes:

Buy 75.0%

Sell 15.0%

Hold 10.0%

RESEARCH REPORTS

Not Rated SEE REPORTS >

pdf

Accumulate SEE REPORTS >

pdf